EcoDrugPlus

Sodium Channel Epithelial 1 Subunit Beta

Ensembl ID : ENSG00000168447
Gene: SCNN1B
Gene Synonyms: ENACBETA
3 APIs:
6 Enzyme and pathways 8 Cross references
151 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Sodium Channel Epithelial 1 Subunit Gamma

Ensembl ID : ENSG00000166828
Gene: SCNN1G
Gene Synonyms: ENACGAMMA,SCNEG
3 APIs:
6 Enzyme and pathways 8 Cross references
155 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Sodium Voltage-Gated Channel Alpha Subunit 1

Ensembl ID : ENSG00000144285
Gene: SCN1A
Gene Synonyms: FEB3,GEFSP2,HBSCI,NAC1,NAV1.1,SCN1,SMEI
58 APIs:
8 Enzyme and pathways 9 Cross references
140 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Sodium Voltage-Gated Channel Alpha Subunit 10

Ensembl ID : ENSG00000185313
Gene: SCN10A
Gene Synonyms: HPN3,NAV1.8,PN3,SNS
62 APIs:
8 Enzyme and pathways 8 Cross references
302 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Sodium Voltage-Gated Channel Alpha Subunit 11

Ensembl ID : ENSG00000168356
Gene: SCN11A
Gene Synonyms: NAN,NAV1.9,SCN12A,SNS-2
59 APIs:
8 Enzyme and pathways 8 Cross references
96 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Sodium Voltage-Gated Channel Alpha Subunit 2

Ensembl ID : ENSG00000136531
Gene: SCN2A
Gene Synonyms: HBSCI,HBSCII,NAV1.2,SCN2A1,SCN2A2
58 APIs:
11 Enzyme and pathways 8 Cross references
130 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Sodium Voltage-Gated Channel Alpha Subunit 3

Ensembl ID : ENSG00000153253
Gene: SCN3A
Gene Synonyms: NAV1.3
58 APIs:
11 Enzyme and pathways 8 Cross references
133 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Sodium Voltage-Gated Channel Alpha Subunit 4

Ensembl ID : ENSG00000007314
Gene: SCN4A
Gene Synonyms: HYKPP,HYPP,NAV1.4,SKM1
62 APIs:
8 Enzyme and pathways 8 Cross references
192 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Sodium Voltage-Gated Channel Alpha Subunit 5

Ensembl ID : ENSG00000183873
Gene: SCN5A
Gene Synonyms: CDCD2,CMD1E,CMPD2,HB1,HB2,HBBD,HH1,ICCD,IVF,LQT3,NAV1.5,PFHB1,SSS1
65 APIs:
8 Enzyme and pathways 9 Cross references
94 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Sodium Voltage-Gated Channel Alpha Subunit 8

Ensembl ID : ENSG00000196876
Gene: SCN8A
Gene Synonyms: CERIII,CIAT,MED,NACH6,NAV1.6,PN4
58 APIs:
8 Enzyme and pathways 9 Cross references
276 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Sodium Voltage-Gated Channel Alpha Subunit 9

Ensembl ID : ENSG00000169432
Gene: SCN9A
Gene Synonyms: ETHA,NAV1.7,NE-NA,NENA,PN1
65 APIs:
11 Enzyme and pathways 9 Cross references
109 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Solute Carrier Family 10 Member 2

Ensembl ID : ENSG00000125255
Gene: SLC10A2
Gene Synonyms: ASBT,IBAT,ISBT,NTCP2
6 APIs:
5 Enzyme and pathways 8 Cross references
211 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).